New Key Statistics Module, Z-Score and F-Score
NAS:ACHL Key Ratios
Market Cap $ M | 39.29 |
Enterprise Value $ M | -67.98 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.31 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -1.60 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.96 |
EV-to-EBITDA | 0.99 |
PEG | -- |
Shares Outstanding M | 42.70 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 9.63 |
Current Ratio | 9.63 |
ROA % (ttm) | -36.28 |
ROE % (ttm) | -41.03 |
ROIC % (ttm) | -235.13 |
Dividend Yield % | -- |
Altman Z-Score | -- |
ACHL Number of Guru Trades
ACHL Volume of Guru Trades
Gurus Latest Trades with NAS:ACHL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ACHL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Achilles Therapeutics PLC Insider Transactions
No Available Data
News about NAS:ACHL
Total 0- 1